INCY Incyte Corporation - Common Stock

NASDAQ · Biotechnology · Ver en SEC EDGAR ↗
$125,49
Precio · Ago 19, 2026
Fundamentales a fecha de Jul 28, 2026
Rango 52S
$81–$133
86% of range
Calificación del Analista
HOLD
33 analysts
Precio Objetivo
$125
P/E (TTM)
19.6
ROE
27.6%
Margen de Beneficio Neto
25.0%

Acerca de Incyte Corporation - Common Stock Descripción general de la empresa de Wikipedia

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.

Leer más

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.

Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.

History

Incyte Corporation was founded by Roy A. Whitfield on April 8, 1991, in Palo Alto, California, as a genomics company. It became a public company in 1993. Subsequently, scientists and chemists were recruited from DuPont to work for Incyte. Incyte moved its headquarters to Delaware, and acquired Maxia Pharmaceuticals in 2003.

In November 2013, Incyte announced its relocation to new headquarters in Wilmington, Delaware, completing the move by the end of 2014. Hervé Hoppenot became CEO in January 2014.

In 2017, the company became part of the S&P 500 Index, which tracks the 500 most widely held U.S. stocks.

In 2015, Incyte established its European headquarters in Geneva, Switzerland, and later moved this headquarters in 2021. The company expanded its Delaware headquarters, including the addition of a research and development facility, in 2022. Incyte acquired Villaris Therapeutics in 2022, and Escient Pharmaceuticals in 2024.

For 2025, the company reported $5.141 billion in revenue, $6.957 billion in assets and $1.286 billion in net income. Incyte is publicly traded on the NASDAQ under the symbol INCY. Incyte now operates out of North America, Asia, and Europe. Bill Meury became CEO in 2025. Meury replaced Hoppenot, who retired after 11 years in the position.

Pharmaceuticals

Incyte Corporation currently has seven marketed and co-marketed pharmaceutical products, including Jakafi (ruxolitinib), Pemazyre (pemigatinib), Monjuvi (tafasitamab-cxix), Opzelura (Ruxolitinib), Tabrecta (capmatinib), Olumiant (Baricitinib), and Iclusig (ponatinib).

In 2013, Novartis acquired Incyte's c-Met inhibitor capmatinib (INC280, INCB028060), which is marketed under the brand name Tabrecta.

As of 2014, the company was developing baricitinib, an oral JAK1 and JAK2 inhibitor drug for rheumatoid arthritis in partnership with Eli Lilly. It gained EU approval in February 2017. In April 2017, the US FDA issued a rejection, citing concerns about dosing and safety. In May 2018, baricitinib was approved in the United States for the treatment of rheumatoid arthritis under the brand name Olumiant.

As of 2016 epacadostat, an indoleamine 2,3-dioxygenase (IDO1) inhibitor, was in development for various cancers and was in combination trials with Merck's pembrolizumab (Keytruda) and Bristol Myers Squibb's nivolumab (Opdivo).

Acquisition history

Incyte has made a total of 3 acquisitions.

Maxia Pharmaceuticals (2003): An early acquisition in Incyte's history, the company purchased Maxia in 2003 for $42 million.

Villaris Therapeutics (2022): This acquisition was valued at approximately $1.4 billion and included an upfront payment along with milestones. It added new assets to Incyte's portfolio for treating vitiligo and other autoimmune conditions.

Escient Pharmaceuticals (2024): In May 2024, Incyte acquired this San Diego-based, clinical-stage company for $750 million. The acquisition provided Incyte with two oral drug candidates for inflammatory diseases, EP262 and EP547.

Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗

Wikidata ↗

INCY Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

Precio
$125.48
Capitalización Bursátil
$24.90B
P/E (TTM)
19.6
BPA (TTM)
$6.41
Ingresos (TTM)
$5.14B
Rendimiento div.
—
ROE
27.6%
Deuda/Capital
—
Rango 52S
$81 – $133

INCY Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

Ingresos y Beneficio Neto $5.14B
10-point trend, +365.0%
2016-12-31 → 2025-12-31
BPA $6.41
10-point trend, +1087.0%
2016-12-31 → 2025-12-31
Flujo de caja libre —
6-point trend, +537.3%
2017-12-31 → 2022-12-31
Márgenes 25.0%

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Métrica
Tendencia a 5 años
INCY
Mediana de Pares
P/E (TTM)
5-point trend, -10.4%
19.6
17.7
P/S (TTM) (P/V (TTM))
5-point trend, -46.7%
4.8
6.8
P/B (P/C)
5-point trend, -48.1%
4.8
6.4

Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC

Métrica
Tendencia a 5 años
INCY
Mediana de Pares
Operating Margin (Margen Operativo)
5-point trend, +397.9%
29.5%
—
Net Profit Margin (Margen de Beneficio Neto)
5-point trend, +325.7%
25.0%
20.3%
ROA
5-point trend, +345.3%
20.8%
11.4%
ROE
5-point trend, +333.2%
27.6%
16.8%
ROIC
5-point trend, +276.2%
22.7%
—

Salud financiera Deuda, liquidez, solvencia — solidez del balance general

Métrica
Tendencia a 5 años
INCY
Mediana de Pares
Current Ratio (Ratio corriente)
5-point trend, -11.3%
3.3
3.4
Quick Ratio (Ratio Rápido)
5-point trend, -14.7%
2.0
—

Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años

Métrica
Tendencia a 5 años
INCY
Mediana de Pares
Revenue YoY (Ingresos interanuales)
5-point trend, +72.2%
21.2%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
5-point trend, +72.2%
14.8%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
5-point trend, +72.2%
14.0%
—
EPS YoY (EPS interanual)
5-point trend, +50.1%
4173.3%
—
Net Income YoY (Beneficio Neto interanual)
5-point trend, +35.6%
3845.0%
—

Métricas por acción BPA, valor contable por acción, flujo de caja por acción, dividendo por acción

Métrica
Tendencia a 5 años
INCY
Mediana de Pares
EPS (Diluted) (BPA (Diluido))
5-point trend, +50.1%
$6.41
—

Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar

Métrica
Tendencia a 5 años
INCY
Mediana de Pares

INCY Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

COMPRA 33 analistas
  • Compra fuerte 8 24,2%
  • Compra 9 27,3%
  • Mantener 16 48,5%
  • Venta 0 0,0%
  • Venta fuerte 0 0,0%

Precio objetivo a 12 meses

23 analistas · 2026-08-18
Objetivo mediano $120.00 -4,4%
Objetivo medio $125.17 -0,2%

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

Sorpresa Media
0.33%
Período EPS Actual EPS est. Sorpresa
30 de junio de 2026 $3.09 $2.14 0.95%
31 de marzo de 2026 $1.81 $1.40 0.41%
31 de diciembre de 2025 $1.80 $1.97 -0.17%
30 de septiembre de 2025 $2.26 $1.69 0.57%
30 de junio de 2025 $1.57 $1.50 0.07%
31 de marzo de 2025 $1.16 $1.04 0.12%

Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector

Ticker Capitalización Bursátil P/E Ingresos interanuales Margen Neto ROE Margen Bruto
INCY $19.60B 15.4 21.2% 25.0% 27.6% —
RVMD — — — — — —
NTRA $32.00B -150.7 35.9% -9.0% -14.1% —
BIIB $25.84B 20.0 2.2% 13.1% 7.2% —
ALNY $52.64B 170.7 65.2% 8.5% 60.4% —
INSM $37.29B -27.1 66.7% -210.5% -128.4% —
MRNA $11.62B -4.1 -39.9% -145.2% -31.3% —
UTHR $21.27B 17.5 10.6% 41.9% 18.7% 87.9%
BBIO $14.90B -20.2 126.3% -146.0% 41.2% —
NBIX $14.20B 30.4 21.4% 16.7% 16.1% —
BMRN $11.43B 33.0 12.9% 10.8% 5.8% —

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

Estado de resultados 17
Datos anuales de Estado de resultados para INCY
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +905.1% $5.14B $4.24B $3.70B $3.39B $2.99B $2.67B $2.16B $1.88B $1.54B $1.11B $754M $511M
Cost of Revenue 12-point trend, +12287.8% $372M $312M $255M $207M $151M $131M $114M $94M $79M $58M $27M $3M
R&D Expense 12-point trend, +489.9% $2.05B $2.61B $1.63B $1.59B $1.46B $2.22B $1.15B $1.20B $1.33B $582M $480M $348M
SG&A Expense 12-point trend, +730.2% $1.38B $1.24B $1.16B $1.00B $740M $517M $469M $434M $366M $303M $197M $166M
Operating Expenses 12-point trend, +602.4% $3.63B $4.18B $3.08B $2.82B $2.40B $2.93B $1.76B $1.75B $1.78B $961M $703M $516M
Operating Income 12-point trend, +31633.3% $1.51B $61M $621M $579M $586M $-264M $402M $129M $-243M $145M $51M $-5M
Interest Expense 10-point trend, -94.6% · · $3M $3M $2M $2M $2M $2M $7M $39M $46M $47M
Interest Income 4-point trend, +161.1% $106M $129M $158M $40M · · · · · · · ·
Other Non-op 9-point trend, +46.4% $25M $13M $14M $-519.0K $11M $23M $52M $32M $17M · · ·
Pretax Income 12-point trend, +3528.5% $1.66B $317M $834M $529M $570M $-232M $487M $115M $-312M $107M $8M $-49M
Income Tax 12-point trend, +572525.8% $378M $284M $237M $188M $-378M $63M $40M $6M $852.0K $3M $1M $-66.0K
Net Income 10-point trend, +1134.5% $1.29B $33M $598M $341M $949M $-296M $447M $109M $-313M $104M · ·
EPS (Basic) 12-point trend, +2372.4% $6.59 $0.16 $2.67 $1.53 $4.30 $-1.36 $2.08 $0.52 $-1.53 $0.55 $0.04 $-0.29
EPS (Diluted) 12-point trend, +2310.3% $6.41 $0.15 $2.65 $1.52 $4.27 $-1.36 $2.05 $0.51 $-1.53 $0.54 $0.03 $-0.29
Shares (Basic) 12-point trend, +16.2% 195,204,000 207,110,000 223,628,000 222,004,000 220,428,000 218,073,000 214,913,000 212,383,000 204,580,000 187,873,000 179,601,000 167,947,000
Shares (Diluted) 12-point trend, +19.5% 200,700,000 210,530,000 225,928,000 223,958,000 222,074,000 218,073,000 217,657,000 215,635,000 204,580,000 194,125,000 187,302,000 167,947,000
EBITDA 9-point trend, +4292.8% $1.61B $151M · $647M $644M $-212M $457M $184M $-192M · · $37M
Balance general 27
Datos anuales de Balance general para INCY
Métrica Tendencia 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +584.9% $3.10B $1.69B $3.21B $2.95B $2.06B $1.51B $1.83B $1.16B $900M $652M $521M $452M
Short-term Investments 6-point trend, +92.5% · · · · · · $285M $274M $270M $156M $186M $148M
Inventory 12-point trend, +28129.1% $101M $59M $63M $42M $28M $16M $11M $7M $6M $4M $2M $358.0K
Prepaid Expense 12-point trend, +1449.0% $318M $169M $183M $167M $126M $60M $44M $79M $62M $33M $18M $21M
Current Assets 12-point trend, +639.3% $5.02B $3.24B $4.65B $4.09B $3.12B $2.36B $2.48B $1.83B $1.50B $994M $842M $680M
PP&E (Net) 12-point trend, +793.6% $731M $763M $752M $739M $724M $560M $378M $320M $260M $168M $86M $82M
PP&E (Gross) 12-point trend, +849.6% $1.11B $1.09B $1.02B $952M $900M $704M $499M $423M $334M $219M $131M $116M
Accum. Depreciation 12-point trend, +981.7% $375M $328M $270M $213M $176M $144M $122M $103M $75M $52M $45M $35M
Goodwill 10-point trend, -14.5% $133M $156M $156M $156M $156M $156M $156M $156M $156M $156M · ·
Intangibles 4-point trend, +11535.6% · · · · · · · · $237M $270M $12M $2M
Other Non-current Assets 11-point trend, +47.9% $18M $11M $52M $25M $37M $39M $49M $19M $2M $3M $12M ·
Total Assets 12-point trend, +773.6% $6.96B $5.44B $6.78B $5.84B $4.93B $3.56B $3.43B $2.65B $2.30B $1.64B $1.01B $796M
Accounts Payable 12-point trend, +758.2% $210M $197M $110M $278M $172M $99M $84M $104M $68M $76M $30M $24M
Accrued Liabilities 12-point trend, +1556.5% $1.03B $1.21B $936M $701M $534M $378M $286M $229M $199M $127M $87M $62M
Current Liabilities 12-point trend, +585.4% $1.52B $1.64B $1.24B $1.16B $854M $631M $513M $425M $375M $274M $168M $221M
Capital Leases 7-point trend, +22.4% $15M $17M $14M $14M $16M $14M $12M · · · · ·
Deferred Tax · · · · · · · · · · · $20M
Other Non-current Liabilities 12-point trend, +203.0% $165M $168M $149M $99M $70M $58M $40M $22M $20M $13M $48M $55M
Total Liabilities 12-point trend, +103.9% $1.79B $2.00B $1.59B $1.47B $1.16B $950M $828M $720M $672M $1.22B $836M $878M
Long-term Debt 5-point trend, +2170.7% · · · · · · · $19.09B $27M $750M $750M $841M
Total Debt · · · · · · · · · · · $689M
Common Stock 12-point trend, +15.8% $198.0K $193.0K $224.0K $223.0K $221.0K $219.0K $216.0K $213.0K $211.0K $189.0K $187.0K $171.0K
Retained Earnings 12-point trend, +112.0% $214M $-1.07B $160M $-437M $-778M $-1.73B $-1.43B $-1.88B $-1.99B $-1.67B $-1.78B $-1.79B
AOCI 12-point trend, +1302.9% $25M $-13M $13M $15M $-19M $-15M $-16M $-10M $-7M $-3M $-809.0K $2M
Stockholders' Equity 12-point trend, +6430.5% $5.17B $3.45B $5.19B $4.37B $3.77B $2.61B $2.60B $1.93B $1.63B $419M $171M $-82M
Liabilities + Equity 12-point trend, +773.6% $6.96B $5.44B $6.78B $5.84B $4.93B $3.56B $3.43B $2.65B $2.30B $1.64B $1.01B $796M
Shares Outstanding 12-point trend, +16.1% 198,460,009 193,434,305 224,286,862 222,746,719 221,084,433 219,489,329 216,177,830 213,274,660 211,262,906 188,848,752 186,650,249 170,876,619
Flujo de Efectivo 16
Datos anuales de Flujo de Efectivo para INCY
Métrica Tendencia 202520242023202220212020201920182017201620152014
D&A 12-point trend, +125.3% $93M $89M $83M $68M $58M $52M $55M $55M $52M $58M $45M $41M
Stock-based Comp 12-point trend, +301.2% $249M $266M $216M $188M $183M $178M $167M $148M $133M $96M $70M $62M
Deferred Tax 9-point trend, +30868.3% $248M $-86M $-159M $57M $-466M $-350.0K $-377.0K $-459.0K $-805.0K · · ·
Amort. of Intangibles 10-point trend, +111.9% $27M $24M $22M $22M $22M $22M $22M $22M $22M $13M · ·
Other Non-cash 7-point trend, -2025.4% $-463M $33M · $316M $26M $-58M $43M $24M · · · ·
Operating Cash Flow 12-point trend, +5283.5% $1.41B $335M $496M $970M $749M $-125M $711M $336M $-93M $305M $89M $26M
CapEx 9-point trend, +179.2% · · · $78M $181M $187M $78M $73M $111M $120M $26M $28M
Investing Cash Flow 11-point trend, +2.3% $-103M $158M $-208M $-79M $-208M $-269M $-87M $-86M $-350M $-232M $-105M ·
Stock Issued · · · · · · · · $649M · · ·
Stock Repurchased 4-point trend, +0.00 $0 $2.00B $0 $0 · · · · · · · ·
Net Stock Activity 3-point trend, -100.0% $0 $-2.00B · · · · · · $649M · · ·
Financing Cash Flow 11-point trend, +19.2% $101M $-2.02B $-20M $-794.0K $6M $72M $46M $15M $690M $45M $85M ·
Net Change in Cash 12-point trend, +7471.0% $1.41B $-1.53B $262M $894M $544M $-319M $669M $265M $247M $117M $69M $-19M
Taxes Paid 10-point trend, +22788.7% $212M $373M $378M $136M $68M $71M $34M $5M $6M $927.0K · ·
Free Cash Flow 7-point trend, +55168.4% · · · $892M $568M $-312M $633M $263M $-204M · · $-2M
Levered FCF 7-point trend, +1940.2% · · · $890M $565M $-315M $631M $261M $-211M · · $-48M
Rentabilidad 7
Datos anuales de Rentabilidad para INCY
Métrica Tendencia 202520242023202220212020201920182017201620152014
Operating Margin 9-point trend, +3234.0% 29.5% 1.5% · 17.1% 19.6% -9.9% 18.6% 6.9% -15.9% · · -0.94%
Net Margin 7-point trend, +330.1% 25.0% 0.77% · 10.0% 31.8% -11.1% 20.7% 5.8% · · · ·
Pretax Margin 9-point trend, +441.1% 32.4% 7.5% · 15.6% 19.1% -8.7% 22.6% 6.1% -20.3% · · -9.5%
EBITDA Margin 9-point trend, +336.9% 31.3% 3.5% · 19.1% 21.6% -7.9% 21.1% 9.8% -12.5% · · 7.2%
ROA 7-point trend, +368.4% 20.8% 0.53% · 6.3% 22.3% -8.5% 14.7% 4.4% · · · ·
ROE 7-point trend, +369.5% 27.6% 0.99% · 7.9% 27.4% -11.8% 17.8% 5.9% · · · ·
ROIC 9-point trend, +2968.4% 22.7% 0.18% · 8.5% 25.8% -12.9% 14.2% 6.4% -15.0% · · -0.79%
Liquidez y Solvencia 4
Datos anuales de Liquidez y Solvencia para INCY
Métrica Tendencia 202520242023202220212020201920182017201620152014
Current Ratio 9-point trend, +5.0% 3.3 2.0 · 3.5 3.7 3.7 4.8 4.3 4.0 · · 3.2
Quick Ratio 9-point trend, -24.6% 2.0 1.0 · 2.6 2.4 2.4 4.1 3.4 3.1 · · 2.7
Debt / Equity · · · · · · · · · · · -8.4
Interest Coverage 7-point trend, +211936.5% · · · 217.3 307.0 -121.3 216.7 83.7 -35.3 · · -0.1
Eficiencia 2
Datos anuales de Eficiencia para INCY
Métrica Tendencia 202520242023202220212020201920182017201620152014
Asset Turnover 9-point trend, +18.3% 0.8 0.7 · 0.6 0.7 0.8 0.7 0.8 0.8 · · 0.7
Inventory Turnover 9-point trend, -40.8% 4.7 5.1 · 5.9 6.8 9.4 12.4 14.0 15.0 · · 7.9
Por Acción 5
Datos anuales de Por Acción para INCY
Métrica Tendencia 202520242023202220212020201920182017201620152014
Book Value / Share 8-point trend, +237.3% $26.04 $17.82 · $19.62 $17.05 $11.90 $12.02 $9.03 $7.72 · · ·
Revenue / Share 8-point trend, +241.1% $25.62 $20.15 · $15.16 $13.45 $12.23 $9.92 $8.73 $7.51 · · ·
Cash Flow / Share 8-point trend, +1649.6% $7.04 $1.59 · $4.33 $3.37 $-0.57 $3.27 $1.56 $-0.45 · · ·
Cash / Share 8-point trend, +266.6% $15.61 $8.73 · $13.25 $9.31 $6.89 $8.48 $5.46 $4.26 · · ·
EPS (TTM) 12-point trend, +2310.3% $6.41 $0.15 $2.65 $1.52 $4.27 $-1.36 $2.05 $0.51 $-1.53 $0.54 $0.03 $-0.29
Tasas de Crecimiento 7
Datos anuales de Tasas de Crecimiento para INCY
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, +77.1% 21.2% 14.8% 8.9% 13.7% 12.0% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +29.2% 14.8% 12.4% 11.5% · · · · · · · · ·
Revenue CAGR 5Y 14.0% · · · · · · · · · · ·
EPS YoY 4-point trend, +6580.3% 4173.3% -94.3% 74.3% -64.4% · · · · · · · ·
EPS CAGR 3Y 2-point trend, +191.5% 61.6% -67.2% · · · · · · · · · ·
Net Income YoY 4-point trend, +6099.3% 3845.0% -94.5% 75.4% -64.1% · · · · · · · ·
Net Income CAGR 3Y 2-point trend, +182.6% 55.7% -67.5% · · · · · · · · · ·
Valoración (TTM) 10
Datos anuales de Valoración (TTM) para INCY
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +905.1% $5.14B $4.24B $3.70B $3.39B $2.99B $2.67B $2.16B $1.88B $1.54B $1.11B $754M $511M
Net Income TTM 10-point trend, +1134.5% $1.29B $33M $598M $341M $949M $-296M $447M $109M $-313M $104M · ·
Market Cap 8-point trend, -2.0% $19.60B $13.36B · $17.89B $16.23B $19.09B $18.88B $13.56B $20.01B · · ·
P/E 12-point trend, +106.1% 15.4 460.5 23.7 52.8 17.2 -64.0 42.6 124.7 -61.9 185.7 3615.0 -252.1
P/S 8-point trend, -70.7% 3.8 3.2 · 5.3 5.4 7.2 8.7 7.2 13.0 · · ·
P/B 8-point trend, -69.1% 3.8 3.9 · 4.1 4.3 7.3 7.3 7.0 12.3 · · ·
P / Tangible Book 6-point trend, -49.9% 3.9 4.1 2.8 4.2 4.5 7.8 · · · · · ·
P / Cash Flow 8-point trend, +106.4% 13.9 39.8 · 18.4 21.7 -153.2 26.6 40.3 -215.2 · · ·
P / FCF 6-point trend, +120.4% · · · 20.1 28.5 -61.2 29.8 51.6 -98.1 · · ·
Earnings Yield 12-point trend, +1722.5% 6.5% 0.22% 4.2% 1.9% 5.8% -1.6% 2.4% 0.80% -1.6% 0.54% 0.03% -0.40%

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

Estado de resultados
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ingresos $5.14B$4.24B$3.70B$3.39B$2.99B
Margen Operativo % 29.5%1.5%—17.1%19.6%
Beneficio neto $1.29B$33M$598M$341M$949M
EPS Diluido $6.41$0.15$2.65$1.52$4.27
Balance general
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ratio corriente 3.32.0—3.53.7
Ratio Rápido 2.01.0—2.62.4
Flujo de Efectivo
2025-12-312024-12-312023-12-312022-12-312021-12-31
Flujo de caja libre ———$892M$568M

Últimas noticias Noticias recientes que mencionan a esta empresa

Señales de trading Señales recientes de compra/venta con precio de entrada y ratio riesgo/recompensa

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos

📊

Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.

Tu selección se guarda y te sigue en todos los tickers.

Propietarios institucionales (13F) 929 declarantes · $16.2B total · A fecha de 30 de junio de 2026

Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.

Actividad institucional — Q2 2026 vs trimestre anterior
Nuevas posiciones Posiciones cerradas Aumentado Disminuido Cambio neto de acciones
130 (+6 vs trimestre anterior) 66 (-30 vs trimestre anterior) 347 (+33 vs trimestre anterior) 261 (-23 vs trimestre anterior) -2.3M

Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.

Institución Valor Acciones % de 13F rastreadas Tipo
BAKER BROS. ADVISORS LP $3 487 217 729 30 762 330 21,55% Acciones
Dodge & Cox $1 355 482 475 11 957 326 8,38% Acciones
VANGUARD CAPITAL MANAGEMENT LLC $1 249 713 401 11 024 289 7,72% Acciones
STATE STREET CORP $1 102 124 009 9 722 336 6,81% Acciones
VANGUARD PORTFOLIO MANAGEMENT LLC $883 198 076 7 791 091 5,46% Acciones
GEODE CAPITAL MANAGEMENT, LLC $472 254 570 4 183 857 2,92% Acciones
RENAISSANCE TECHNOLOGIES LLC $398 135 284 3 512 132 2,46% Acciones
WELLINGTON MANAGEMENT GROUP LLP $384 786 803 3 394 379 2,38% Acciones
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $311 168 439 2 744 958 1,92% Acciones
Robeco Institutional Asset Management B.V. $276 795 075 2 441 735 1,71% Acciones
TWO SIGMA INVESTMENTS, LP $227 123 448 2 003 559 1,40% Acciones
DIMENSIONAL FUND ADVISORS LP $201 199 603 1 774 874 1,24% Acciones
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $191 845 249 1 692 354 1,19% Acciones
FIRST TRUST ADVISORS LP $180 015 041 1 587 996 1,11% Acciones
VICTORY CAPITAL MANAGEMENT INC $167 811 569 1 480 342 1,04% Acciones
Caisse de depot et placement du Quebec $155 360 220 1 370 503 0,96% Acciones
AustralianSuper Pty Ltd $135 634 220 1 196 491 0,84% Acciones
NORGES BANK $126 861 970 1 119 107 0,78% Acciones
FMR LLC $116 316 542 1 026 081 0,72% Acciones
ROYAL BANK OF CANADA $115 263 000 1 016 790 0,71% Acciones
VANGUARD FIDUCIARY TRUST CO $106 959 694 943 540 0,66% Acciones
ARMISTICE CAPITAL, LLC $102 024 567 900 005 0,63% Acciones
PANAGORA ASSET MANAGEMENT INC $99 970 937 881 889 0,62% Acciones
GOLDMAN SACHS GROUP INC $97 568 045 860 692 0,60% Acciones
VANGUARD GROUP INC $91 396 622 925 348 0,56% Acciones
Sound Shore Management Inc /CT/ $85 895 479 757 723 0,53% Acciones
JACOBS LEVY EQUITY MANAGEMENT, INC $82 953 901 731 774 0,51% Acciones
Gotham Asset Management, LLC $81 567 621 719 545 0,50% Acciones
Pictet Asset Management Holding SA $81 315 880 713 354 0,50% Acciones
VIRGINIA RETIREMENT SYSTEMS ET Al $75 887 460 768 325 0,47% Acciones
MACKENZIE FINANCIAL CORP $71 967 956 634 862 0,44% Acciones
LOS ANGELES CAPITAL MANAGEMENT LLC $65 633 852 578 986 0,41% Acciones
Legal & General Group Plc $63 331 398 558 675 0,39% Acciones
SEB Asset Management AB $63 307 742 558 467 0,39% Acciones
GLENMEDE TRUST CO NA $60 308 653 532 010 0,37% Acciones
Woodline Partners LP $58 118 538 512 690 0,36% Acciones
MARSHALL WACE, LLP $56 804 130 501 095 0,35% Acciones
BNP PARIBAS FINANCIAL MARKETS $56 779 870 500 881 0,35% Acciones
WORLDQUANT MILLENNIUM ADVISORS LLC $55 184 782 486 810 0,34% Acciones
BlackRock, Inc. $54 675 002 482 313 0,34% Acciones
Swiss National Bank $54 058 437 476 874 0,33% Acciones
Glenmede Investment Management, LP $53 145 338 626 640 0,33% Acciones
Vinva Investment Management Ltd $53 069 578 462 843 0,33% Acciones
CANADA PENSION PLAN INVESTMENT BOARD $50 161 800 442 500 0,31% Acciones
California Public Employees Retirement System $48 730 290 429 872 0,30% Acciones
RHUMBLINE ADVISERS $48 578 406 428 533 0,30% Acciones
IEQ CAPITAL, LLC $48 141 997 424 682 0,30% Acciones
Mitsubishi UFJ Asset Management Co., Ltd. $46 733 567 412 258 0,29% Acciones
Sumitomo Mitsui Trust Group, Inc. $44 634 140 393 738 0,28% Acciones
Vanguard Global Advisers, LLC $43 080 994 380 037 0,27% Acciones
MORGAN STANLEY $42 894 746 378 394 0,27% Acciones
Swedbank AB $42 100 431 371 387 0,26% Acciones
AMERICAN CENTURY COMPANIES INC $39 177 443 345 602 0,24% Acciones
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $38 530 157 339 892 0,24% Acciones
CAPITAL FUND MANAGEMENT S.A. $38 125 008 336 318 0,24% Acciones
VANGUARD ASSET MANAGEMENT, Ltd $37 984 782 335 081 0,23% Acciones
Grantham, Mayo, Van Otterloo & Co. LLC $36 114 682 318 584 0,22% Acciones
Aware Super Pty Ltd as trustee of Aware Super $34 779 982 306 810 0,21% Acciones
Arbejdsmarkedets Tillaegspension $33 826 624 298 400 0,21% Acciones
BARCLAYS PLC $32 329 252 285 191 0,20% Acciones
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $32 129 398 283 428 0,20% Acciones
Ensign Peak Advisors, Inc $30 602 212 269 956 0,19% Acciones
Illinois Municipal Retirement Fund $29 511 916 260 338 0,18% Acciones
WINTON GROUP Ltd $28 839 691 254 408 0,18% Acciones
PFA Pension, Forsikringsaktieselskab $28 624 373 252 509 0,18% Acciones
Universal- Beteiligungs- und Servicegesellschaft mbH $26 717 581 236 172 0,17% Acciones
TODD ASSET MANAGEMENT LLC $26 568 750 234 375 0,16% Acciones
BANK OF AMERICA CORP /DE/ $25 899 133 228 468 0,16% Acciones
PRINCIPAL FINANCIAL GROUP INC $24 961 078 220 193 0,15% Acciones
Andra AP-fonden $24 381 598 259 048 0,15% Acciones
Quantinno Capital Management LP $24 309 704 214 446 0,15% Acciones
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main $24 037 194 212 043 0,15% Acciones
Baird Financial Group, Inc. $23 690 539 208 985 0,15% Acciones
Eurizon Capital SGR S.p.A. $23 250 000 204 785 0,14% Acciones
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $22 709 932 241 287 0,14% Acciones
Korea Investment CORP $22 164 827 195 526 0,14% Acciones
KLP KAPITALFORVALTNING AS $21 799 695 192 305 0,13% Acciones
Catalio Capital Management, LP $21 722 837 191 627 0,13% Acciones
PRUDENTIAL FINANCIAL INC $21 650 853 190 992 0,13% Acciones
ROYAL LONDON ASSET MANAGEMENT LTD $21 575 016 190 323 0,13% Acciones
Fideuram Asset Management (Ireland) dac $20 928 446 213 883 0,13% Acciones
FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND $20 401 285 179 969 0,13% Acciones
APG Asset Management N.V. $20 193 310 203 661 0,12% Acciones
Zurcher Kantonalbank (Zurich Cantonalbank) $19 499 734 172 016 0,12% Acciones
SECTOR GAMMA AS $19 356 560 170 753 0,12% Acciones
MARTINGALE ASSET MANAGEMENT L P $19 137 209 168 818 0,12% Acciones
CWM, LLC $19 084 906 202 772 0,12% Acciones
Bridgewater Associates, LP $19 073 160 168 253 0,12% Acciones
ALLIANCEBERNSTEIN L.P. $18 937 791 201 209 0,12% Acciones
Candriam S.C.A. $18 443 367 162 854 0,11% Acciones
Focus Partners Wealth $18 354 947 161 917 0,11% Acciones
DNB Asset Management AS $18 304 239 161 470 0,11% Acciones
SEI INVESTMENTS CO $18 019 140 158 955 0,11% Acciones
Trails Edge Capital Partners, LP $17 570 800 155 000 0,11% Acciones
Jefferies Financial Group Inc. $17 321 295 152 799 0,11% Acciones
SAWGRASS ASSET MANAGEMENT LLC $17 250 671 152 176 0,11% Acciones
Mitsubishi UFJ Trust & Banking Corp $17 215 756 151 868 0,11% Acciones
AVIVA PLC $16 882 025 148 924 0,10% Acciones
Driehaus Capital Management LLC $16 794 397 148 151 0,10% Acciones
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $16 681 037 147 151 0,10% Acciones

Informantes de la empresa 61 insiders · 32 directivos · 17 consejeros

Insider Rol Última actividad Acciones en propiedad Compras 12m Ventas 12m Neto 12m
William Meury Chief Executive Officer 16 de julio de 2026 A 183 129 0 0 $0
Herve Hoppenot Special Advisor to the CEO 15 de julio de 2025 F 517 146 0 0 $0
Christiana Stamoulis EVP & Chief Financial Officer 15 de julio de 2025 A 125 759 0 0 $0
David W Gryska Executive Vice President, CFO 16 de julio de 2018 F 10 235 0 0 $0
David C Hastings Chief Financial Officer 5 de junio de 2014 M 8 500 0 0 $0
Lee Heeson EVP, Head of Incyte Intl 23 de julio de 2026 A 32 778 0 0 $0
Michael James Morrissey EVP, Head of Tech. Operations 23 de julio de 2026 A 81 515 0 0 $0
Richard A. Hoffman EVP & General Counsel 16 de julio de 2026 A 16 861 0 0 $0
David H Gardner EVP, Chief Strategy Officer 16 de julio de 2026 A 16 824 0 0 $0
Ramitpal K Basi EVP, Human Resources 16 de julio de 2026 A 11 497 0 0 $0
Mohamed Khairie Issa EVP, Head of U.S. Commercial 16 de julio de 2026 A 71 797 0 1 $-125 706
Thomas Tray Principal Accounting Officer 16 de julio de 2026 A 21 699 0 1 $-263 900
Steven H Stein CMO & Head of Late-Stage Dev. 16 de julio de 2026 A 30 916 0 2 $-3 407 541
Sheila A. Denton EVP & General Counsel 15 de agosto de 2025 M 33 200 0 1 $-24 046
Vijay K Iyengar EVP, GMAPPS 16 de julio de 2025 S 40 540 0 0 $0
Barry P Flannelly EVP & General Manager US 16 de julio de 2025 S 35 149 0 0 $0
Matteo Trotta EVP, GM, Dermatology US 15 de julio de 2025 A 15 016 0 0 $0
Paula J Swain EVP, Human Resources 15 de julio de 2025 A 106 482 0 0 $0
Jonathan Elliott Dickinson EVP, General Manager, Europe 12 de septiembre de 2024 S 36 390 0 0 $0
Dashyant Dhanak EVP & Chief Scientific Officer 14 de julio de 2023 A 58 968 0 0 $0
Maria E Pasquale EVP & General Counsel 14 de julio de 2023 A 69 724 0 0 $0
Paul Trower Principal Accounting Officer 19 de enero de 2022 A 32 268 0 0 $0
Yao Wenqing EVP, Head of Discovery Chem 2 de julio de 2021 A 98 575 0 0 $0
Reid M Huber EVP, Chief Scientific Officer 16 de julio de 2018 F 34 571 0 0 $0
Eric H. Siegel EVP, General Counsel 13 de septiembre de 2017 F 21 053 0 0 $0
Richard S Levy EVP, Chief Drug Dev Officer 6 de enero de 2016 M 16 926 0 0 $0
James M Daly EVP, Chief Commercial Officer 23 de junio de 2015 M 3 521 0 0 $0
Patricia S Andrews Chief Commercial Officer 19 de enero de 2012 A — 0 0 $0
Patricia A Schreck EVP, General Counsel 10 de mayo de 2011 M 4 500 0 0 $0
Brian W Metcalf Chief Drug Discovery Scientist 11 de abril de 2011 M 66 504 0 0 $0
Steven M. Friedman EVP, Biology & Preclinical Dev 18 de mayo de 2010 A 38 137 0 0 $0
John A Keller Chief Business Officer 8 de febrero de 2008 A — 0 0 $0
Paul J Clancy Consejero 30 de junio de 2026 A 25 635 0 0 $0
Edmund Harrigan Consejero 30 de junio de 2026 A 23 019 0 0 $0
Katherine A High Consejero 8 de junio de 2026 A 14 983 0 0 $0
Jacqualyn A Fouse Consejero 8 de junio de 2026 A 20 968 0 0 $0
Jean Jacques Bienaime Consejero 8 de junio de 2026 A 24 424 0 0 $0
Otis W Brawley Consejero 8 de junio de 2026 A 12 894 0 0 $0
Susanne Schaffert Consejero 12 de junio de 2024 A 5 720 0 0 $0
Wendy L Dixon Consejero 31 de marzo de 2022 A 17 768 0 0 $0
Paul A Friedman, M.D. Consejero 26 de mayo de 2020 A 256 813 0 0 $0
Paul A Brooke Consejero 31 de marzo de 2020 A 221 911 0 0 $0
Barry A Ariko Consejero 12 de marzo de 2015 M 45 834 0 0 $0
Richard U De Schutter Consejero 5 de marzo de 2015 M 92 290 0 0 $0
Roy A Whitfield Consejero 17 de diciembre de 2013 M 666 082 0 0 $0
John F Niblack Consejero 20 de mayo de 2011 A — 0 0 $0
Fred B Craves Consejero 1 de junio de 2005 A 196 793 0 0 $0
INCYTE CORP Propietario del 10% 25 de enero de 2021 A 3 550 000 0 0 $0
DAMIAL FOUNDATION INC Propietario del 10% 11 de febrero de 2004 S — 0 0 $0
Bonnie J Tisch Propietario del 10% 14 de enero de 2004 S — 0 0 $0

Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto

Activistas y propietarios del %+ 5 7 tenencias

Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.

Declarante Presentado Participación Estado Propósito Presentación
Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB3 LLC, FBB Associates ×21 presentaciones 11 de mayo de 2026 15,60% Enmienda Inversión pasiva SEC
Incyte Corporation ×3 presentaciones 14 de agosto de 2023 — Presentación inicial Estructura de capital SEC
Baker Bros. Advisors, LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB Associates ×2 presentaciones 15 de junio de 2012 — Presentación inicial — SEC
Julian C. Baker, Felix J. Baker ×12 presentaciones 1 de octubre de 2009 — Presentación inicial — SEC
Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada 25 de febrero de 2004 — Presentación inicial — SEC
Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada 29 de septiembre de 2003 — Presentación inicial — SEC
Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada 15 de agosto de 2002 — Presentación inicial — SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Propiedad de ETFs Mantenido por 213 ETFs

El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.

Fondo Ponderación Unidades A fecha de Fuente
BRNY · EA Series Trust 3,64% 211 562 NS 30 de abril de 2026 N-PORT
BUL · Pacer Funds Trust 2,38% 31 787 NS 30 de abril de 2026 N-PORT
SAWG · ETF Series Solutions 2,36% 624 NS 30 de abril de 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 2,19% 201 047 NS 30 de abril de 2026 N-PORT
FGSI · First Trust Exchange-Traded Fund IV 1,98% 623 NS 30 de abril de 2026 N-PORT
SMRI · EA Series Trust 1,96% 111 283 NS 30 de abril de 2026 N-PORT
HTEC · EXCHANGE TRADED CONCEPTS TRUST 1,78% 9 967 NS 30 de abril de 2026 N-PORT
BBP · ETFis Series Trust I 1,59% 9 918 NS 30 de abril de 2026 N-PORT
ABOT · Abacus FCF ETF Trust 1,59% 736 NS 30 de abril de 2026 N-PORT
CALF · Pacer Funds Trust 1,55% 561 166 NS 30 de abril de 2026 N-PORT
NUMG · Nushares ETF Trust 1,44% 53 580 NS 30 de abril de 2026 N-PORT
AGNG · Global X Funds 1,36% 11 515 NS 31 de mayo de 2026 N-PORT
COWG · Pacer Funds Trust 1,21% 275 493 NS 30 de abril de 2026 N-PORT
FLOW · Global X Funds 1,20% 3 543 NS 31 de mayo de 2026 N-PORT
GURU · Global X Funds 1,01% 6 203 NS 30 de abril de 2026 N-PORT
BIB · ProShares Trust 0,97% 7 359 NS 31 de mayo de 2026 N-PORT
LABU · Direxion Shares ETF Trust 0,94% 51 287 NS 30 de abril de 2026 N-PORT
TMFX · RBB Fund, Inc. 0,94% 3 113 NS 31 de mayo de 2026 N-PORT
OASC · Unified Series Trust 0,91% 7 915 NS 31 de mayo de 2026 N-PORT
LSVD · ADVISORS' INNER CIRCLE FUND 0,89% 56 482 NS 30 de abril de 2026 N-PORT
ROE · EA Series Trust 0,87% 23 347 NS 29 de mayo de 2026 N-PORT
JMID · Janus Detroit Street Trust 0,83% 1 595 NS 30 de abril de 2026 N-PORT
JOET · Virtus ETF Trust II 0,79% 19 541 NS 30 de abril de 2026 N-PORT
INFO · Harbor ETF Trust 0,75% 61 119 NS 30 de abril de 2026 N-PORT
CLSE · Trust for Professional Managers 0,71% 45 326 NS 31 de mayo de 2026 N-PORT
FTC · First Trust Exchange-Traded AlphaDE… 0,64% 85 796 NS 30 de abril de 2026 N-PORT
QGRO · AMERICAN CENTURY ETF TRUST 0,64% 146 423 NS 31 de mayo de 2026 N-PORT
EBI · RBB Fund Trust 0,52% 35 279 NS 31 de mayo de 2026 N-PORT
AFMC · First Trust Exchange-Traded Fund VI… 0,48% 7 994 NS 31 de mayo de 2026 N-PORT
AFLG · First Trust Exchange-Traded Fund VI… 0,45% 29 860 NS 31 de mayo de 2026 N-PORT
FLCV · Federated Hermes ETF Trust 0,44% 4 411 NS 31 de mayo de 2026 N-PORT
COWZ · Pacer Funds Trust 0,44% 832 413 NS 30 de abril de 2026 N-PORT
QQWZ · Pacer Funds Trust 0,43% 2 130 NS 30 de abril de 2026 N-PORT
HQGO · Lattice Strategies Trust 0,42% 2 110 NS 30 de abril de 2026 N-PORT
ROUS · Lattice Strategies Trust 0,41% 25 509 NS 30 de abril de 2026 N-PORT
GQQQ · EA Series Trust 0,39% 5 807 NS 29 de mayo de 2026 N-PORT
ESLV · Strategy Shares 0,35% 435 NS 30 de abril de 2026 N-PORT
JPME · J.P. Morgan Exchange-Traded Fund Tr… 0,35% 15 893 NS 30 de abril de 2026 N-PORT
SXQG · EXCHANGE TRADED CONCEPTS TRUST 0,35% 2 420 NS 31 de mayo de 2026 N-PORT
FLCC · Federated Hermes ETF Trust 0,34% 4 284 NS 31 de mayo de 2026 N-PORT
FEX · First Trust Exchange-Traded AlphaDE… 0,33% 52 210 NS 30 de abril de 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0,32% 16 240 NS 30 de abril de 2026 N-PORT
SCHM · SCHWAB STRATEGIC TRUST 0,30% 452 041 NS 31 de mayo de 2026 N-PORT
CSM · ProShares Trust 0,28% 15 357 NS 31 de mayo de 2026 N-PORT
FSMD · FIDELITY COVINGTON TRUST 0,28% 70 109 NS 30 de abril de 2026 N-PORT
FBUF · Fidelity Greenwood Street Trust 0,28% 558 NS 30 de abril de 2026 N-PORT
FYEE · Fidelity Greenwood Street Trust 0,28% 4 865 NS 30 de abril de 2026 N-PORT
LGDX · Tidal Trust III 0,27% 3 928 NS 30 de abril de 2026 N-PORT
TMFE · RBB Fund, Inc. 0,27% 2 374 NS 31 de mayo de 2026 N-PORT
SGLC · RBB Fund, Inc. 0,27% 5 437 NS 31 de mayo de 2026 N-PORT